Open original FDA record ↗Recall record
- FDA identifier
- Z-1232-2007
- Company in FDA record
- Abbott Laboratories Inc.
- FDA classification date
- Sep 18, 2007
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Lipase results are falsely elevated when a MULTIGENT Acetaminophen test is pipetted immediately before a Lipase test from the same sample cup or tube on the ARCHITECT c8000.
Source facts
- Action
- The firm initiated the recall on 06/01/2007 by sending recall letters with attached Customer Reply form via FedEx to each direct account that received the recalled product. Customers were informed of the issue and given instructions for modification to the SmartWash feature in the Lipase Assay Configuration in order to prevent Acetaminophen from contaminating Lipase.
- Initiated
- 2007-06-01
- Root cause
- Other
- Terminated
- 2012-04-05
- Distribution
- Worldwide, including USA, Australia, Brazil, Canada, Chile, El Salvador, Dominican Republic, Ecuador, Germany, Hong Kong, Japan, Mexico, New Zealand, Panama, Puerto Rico, Singapore, South Korea, Thailand, and Venezuela.
- Recall number
- Z-1232-2007
- Recall status
- Terminated
- CDRH record ID
- 54072
- FDA classified
- 2007-09-18
- Recall event number
- 38635